Genetically engineered bacterium for catalytically generating quinoline compounds and application of genetically engineered bacterium

Through genetically engineered bacteria, monoamine oxidase and alcohol oxidase are expressed, and amino alcohol is catalyzed for oxidation cyclization reaction, solving the problems of medium and high temperature and high pressure and high raw material costs in the synthesis of quinoline compounds, and achieving efficient and green production of quinoline compounds.

CN119040234APending Publication Date: 2024-11-29ZHEJIANG UNIV
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202411180851.9
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-08-27
Publication Date
2024-11-29

AI Technical Summary

Technical Problem

The prior art has problems of high temperature and high pressure, pollution and high raw material costs in the synthesis of quinoline compounds. Especially when 1,2,3,4-tetrahydroquinoline is used as a substrate, it is expensive and the reaction conditions are harsh. Moreover, there are few reports of oxidation cyclization reactions using amino alcohol substrates by biocatalytic method.

Method used

Develop a genetically engineered bacteria that expresses monoamine oxidase and alcohol oxidase, and use these enzymes to catalyze the oxidative cyclization reaction of amino alcohols to produce quinoline compounds, avoiding the high temperature, high pressure and high pollution of traditional chemical methods, and using more easily available amino alcohols As a substrate, green production is achieved.

Benefits of technology

It has achieved efficient catalyzing amino alcohol substrates to form quinoline compounds under mild conditions, with high initial substrate conversion rate and high yield of quinoline compounds, simple process, and filled with the biocatalytic method of catalyzing amino alcohol substrate oxidation ring Blanks for synthesis of quinoline.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN119040234A_ABST
    Figure CN119040234A_ABST
Patent Text Reader

Abstract

The invention discloses a genetically engineered bacterium for catalytically generating quinoline compounds and application of the genetically engineered bacterium. The genetically engineered bacterium expresses monoamine oxidase and an enzyme capable of catalyzing alcohol oxidation, and the enzyme capable of catalyzing alcohol oxidation is selected from alcohol oxidase or alcohol dehydrogenase. The invention accidentally finds that the monoamine oxidase coupled alcohol dehydrogenase or alcohol oxidase can catalyze the amino alcohol substrate to prepare the quinoline, and fills the blank that the amino alcohol substrate cannot be synthesized into the quinoline compound by the current biological catalysis method.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention belongs to the technical field of genetic engineering, and specifically relates to a genetic engineering bacterium for catalyzing the generation of quinoline compounds and a use thereof. Background Art

[0002] Quinoline is an important aromatic N-heterocyclic compound. This important skeleton is widely present in many quinoline alkaloids. This type of alkaloid is widely distributed in nature and can be found in plants, animals and microorganisms. This type of alkaloid usually has important biological activities, such as antimalarial, antitumor, antidepressant and other pharmacological activities. In addition to its pharmacological effects in the field of active drugs, quinoline structures have also been widely used in the fields of synthesizing chiral ligands, pesticide chemistry and functional materials.

[0003] In the past few years, great efforts have been made to synthesize quinoline compounds. Traditional chemical synthesis methods such as Skraup, Doebner-Miller, Knorr, etc. usually require the consumption of acidic or toxic and harmful media, produce by-products during the reaction, and require complex post-processing steps after the reaction. In recent years, 1,2,3,4-tetrahydroquinoline has been used as a substrate to obtain quinoline compounds through oxidative dehydrogenation aromatization. It has attracted widespread attention due to its atom economy, sustainability, and avoidance of tedious post-processing steps. However, the synthesis of quinoline by this route requires organic or metal catalysts, such as Cu2-MnO XIt catalyzes 1,2,3,4-tetrahydroquinoline, but the problems of harsh reaction conditions and low selectivity severely limit the development of this synthetic strategy. In addition, people have also developed biocatalytic methods based on this catalytic route, making the synthesis of quinoline compounds more in line with the concept of green chemistry. For example, Huanhuan Jin reported in 2023 that the monoamine oxidase (PpMAO) of Pseudomonas putida KT2440 was used to effectively oxidize and dehydrogenate 1,2,3,4-tetrahydroquinoline; for example, CN116376858A discloses the use of monoamine oxidase from microorganisms as a catalyst in the preparation of quinoline or quinoline derivatives, which clones 10 monoamine oxidase gene sequences into the recombinant expression plasmid pET-28a(+) after codon optimization and transfers them into the expression host E. coli BL21 (DE3), a crude enzyme solution containing monoamine oxidase is obtained, which catalyzes 1,2,3,4-tetrahydroquinoline to prepare quinoline compounds. The results show that the yield of quinoline compounds can reach up to 99%; for example, CN111254170B discloses a method for preparing (S)-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid (I) by multi-enzyme coupling, which constructs an Escherichia coli expressing alcohol dehydrogenase to catalyze (R)-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid racemate or 1,2,3,4-tetrahydroisoquinoline-3-carboxylate racemate to generate (S)-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid.

[0004] However, the substrates of the previous routes are all 1,2,3,4-tetrahydroquinoline compounds, which are relatively expensive, generally priced at 160-180 yuan for 25 mL. Compared with the more easily available raw materials such as aniline or 2-aminobenzaldehyde in traditional chemical synthesis methods, this synthesis strategy needs to be improved in terms of raw material costs. Although these substrates are relatively cheap and easy to obtain, the methods that can use these substrates to synthesize quinoline are mostly chemical methods. Although these chemical methods have advantages in raw material costs, the reaction conditions are harsh and the post-processing is cumbersome; in addition, the reactions for synthesizing quinoline with these substrates are mostly condensation reactions. In the reaction process, it is generally necessary to add an excess of a certain substrate to promote the reaction, which not only increases the waste of raw materials, but also increases the difficulty of subsequent separation and purification.

[0005] Compared with aniline or 2-aminobenzaldehyde substrates, the cost of amino alcohol substrates is not as high as these substrates, but compared with 1,2,3,4-tetrahydroquinoline compounds, amino alcohols have the advantage of cheap and readily available raw materials. Therefore, using easily available amino alcohol substrates as raw materials, synthesizing quinoline structures through intramolecular oxidative cyclization reactions of amino alcohols has gradually become an attractive quinoline synthesis route in recent years. However, there are currently few reports on the use of amino alcohol substrates to synthesize quinoline compounds using biological methods.

[0006] In view of this, it is necessary to develop a process that uses biocatalysts to synthesize quinoline structures through the oxidative cyclization of amino alcohol substrates. This method can not only avoid the shortcomings of high temperature, high pressure and high pollution of traditional chemistry, but also can be synthesized from more readily available raw materials. It is an advanced manufacturing that conforms to the concept of green production. Summary of the invention

[0007] One of the purposes of the present invention is to provide a genetically engineered bacterium for catalyzing the production of quinoline compounds, which expresses monoamine oxidase and an enzyme capable of catalyzing alcohol oxidation, wherein the enzyme capable of catalyzing alcohol oxidation is selected from alcohol oxidase or alcohol dehydrogenase.

[0008] Preferably, the monoamine oxidase is derived from Pseudomonas putida KT2440.

[0009] More preferably, the nucleotide sequence of the monoamine oxidase comprises the sequence shown in SEQ ID NO.14.

[0010] Preferably, the alcohol dehydrogenase is selected from one or more of Bacillus stearothermophilus, Pseudomonas putida KT2440, Pseudomonas entomophila strain L48 and Cyanobacterium Synechocystis PCC6803.

[0011] More preferably, the nucleotide sequence of the alcohol dehydrogenase comprises one or more of the sequences shown in SEQ ID NO.2, SEQ ID NO.4, SEQ ID NO.6 and SEQ ID NO.8.

[0012] Preferably, the alcohol oxidase is selected from one or both of a choline oxidase mutant and a galactose oxidase mutant.

[0013] More preferably, the choline oxidase mutant is derived from Arthrobacter cholorphenolicus.

[0014] More preferably, the galactose oxidase mutant is derived from Fusarium graminearum 2903.

[0015] Further preferably, the nucleotide sequence of the choline oxidase mutant comprises the sequence shown in SEQ ID NO.10.

[0016] Further preferably, the nucleotide sequence of the galactose oxidase mutant comprises the sequence shown in SEQ ID NO.12.

[0017] Preferably, a molecular chaperone plasmid is also expressed, and the molecular chaperone plasmid is selected from one or both of pGro7 and pKJE7.

[0018] Preferably, the engineered bacteria is selected from Escherichia coli.

[0019] The second aspect of the present invention protects a method for constructing a genetically engineered bacterium as described above, comprising the following:

[0020] The nucleic acid molecule encoding the monoamine oxidase and the nucleic acid molecule encoding the enzyme capable of catalyzing alcohol oxidation are introduced into the host to construct and obtain the genetically engineered bacteria.

[0021] The third aspect of the present invention protects a whole-cell catalyst, comprising the genetically engineered bacteria as described above.

[0022] The fourth aspect of the present invention protects the use of the genetically engineered bacteria as described or the whole-cell catalyst as described above in the preparation of quinoline compounds.

[0023] The fifth aspect of the present invention provides a method for preparing a quinoline compound, comprising the following steps:

[0024] The amino alcohol is used as a substrate and the genetically engineered bacteria or the whole cell catalyst as described above are used to react to obtain the quinoline compound.

[0025] Preferably, the amino alcohol is selected from 3-(2-aminophenyl)-1-propanol.

[0026] Preferably, the reaction temperature is 20-50°C.

[0027] Due to the implementation of the above technical solution, the present invention has the following beneficial effects compared with the prior art:

[0028] (1) The present invention unexpectedly discovered that monoamine oxidase coupled with alcohol dehydrogenase or alcohol oxidase can catalyze the oxidative cyclization aromatization of amino alcohols, especially 3-(2-aminophenyl)-1-propanol, thereby realizing the preparation of quinoline compounds using amino alcohols as substrates by biocatalysis, filling the gap in the current biocatalytic method for catalyzing the oxidative cyclization of amino alcohol substrates to synthesize quinoline compounds.

[0029] (2) When the genetically engineered bacteria of the present invention are used to prepare quinoline compounds, the reaction system is simple. In addition to the substrate, only a biocatalyst, a small amount of cosolvent and a normal pressure air atmosphere need to be added. The reaction can be carried out at 20 to 50° C., and the reaction conditions are mild.

[0030] (3) When the genetically engineered bacteria of the present invention are used to prepare quinoline compounds, the conversion rate of the starting substrate is as high as 88-100%, the yield of the quinoline compounds is as high as 82-96%, and the process is simple. BRIEF DESCRIPTION OF THE DRAWINGS

[0031] Figure 1 This is the LC-MS ultraviolet absorption spectrum of the substrate 3-(2-aminophenyl)-1-propanol in Example 2 of the present invention, wherein the retention time is 3.093 min for 3-(2-aminophenyl)-1-propanol.

[0032] Figure 2 The LC-MS ultraviolet absorption spectrum of the product quinoline in Example 2 of the present invention is shown in FIG.

[0033] Figure 3 This is the ultraviolet absorption spectrum detected by LC-MS of samples taken after 24 hours of reaction in the reaction system in Example 3 of the present invention. DETAILED DESCRIPTION

[0034] The first aspect of the present application protects a genetically engineered bacterium that catalyzes the production of quinoline compounds, which expresses monoamine oxidase and an enzyme that can catalyze alcohol oxidation, wherein the enzyme that can catalyze alcohol oxidation is selected from alcohol oxidase or alcohol dehydrogenase.

[0035] Preferably, the alcohol dehydrogenase (ADHs) is selected from one or more of Bacillus stearothermophilus, Pseudomonas putida KT2440, Pseudomonas entomophila strain L48, and Cyanobacterium synechocystis PCC 6803. ADHs can use a variety of alcohols as substrates, but ADHs need to use expensive NAD(P) + As an electron acceptor, its application is greatly limited.

[0036] More preferably, the nucleotide sequence of the alcohol dehydrogenase comprises one or more of the sequences shown in SEQ ID NO.2, SEQ ID NO.4, SEQ ID NO.6 and SEQ ID NO.8.

[0037] The present application found that the alcohol dehydrogenase with the sequence shown in SEQ ID NO. 2 from Cyanobacterium synechocystis PCC 6803 has the highest yield when preparing quinoline, which can reach 19%.

[0038] Preferably, the alcohol oxidase is selected from one or both of an alkali oxidase mutant and a galactose oxidase mutant. Alcohol oxidase can utilize oxygen as an electron acceptor to catalyze the oxidation of alcohols and is an ideal biocatalyst, but the alcohol oxidases discovered so far are too few to meet industrial needs.

[0039] More preferably, the choline oxidase mutant is derived from Arthrobacter cholorphenolicus.

[0040] More preferably, the nucleotide sequence of the choline oxidase mutant comprises SEQ ID NO.10.

[0041] More preferably, the galactose oxidase mutant is derived from Fusarium graminearum 2903.

[0042] More preferably, the nucleotide sequence of the galactose oxidase mutant comprises SEQ ID NO.12.

[0043] Preferably, the monoamine oxidase is derived from Pseudomonas putida KT2440.

[0044] More preferably, the nucleotide sequence of the monoamine oxidase comprises the sequence shown in SEQ ID NO.14.

[0045] Preferably, when constructing and expressing an enzyme capable of catalyzing alcohol oxidation, the shuttle plasmid used is selected from one or both of pET-28a(+) and pRSFDuet-1 plasmids.

[0046] Preferably, the present invention further comprises a molecular chaperone plasmid, wherein the molecular chaperone plasmid is selected from one or both of pGro7 and pKJE7.

[0047] Alcohol dehydrogenase from Cyanobacterium synechocystis PCC 6803 (ADHA, NCBI accession number: ALJ69257.1, the amino acid sequence is shown in SEQ ID NO.1, and the nucleotide sequence is shown in SEQ ID NO.2).

[0048] ADHA amino acid sequence: SEQ ID NO.1

[0049] MIKAYAALEANGKLQPFEYDPGALGANEVEIEVQYCGVCHSDLSMINNEWGISNYPLVPGHEVVGTVAAMGEGVNHVEVGDLVGLGWHSGYCMTCHSCLSGYHNLCATAESTIVGHYGGFGDRVRAKGVSVVKLPKGIDLASAGPLFCGGITVFSPMVELSLKPTAKVAVIGIGGLGHLAVQFLRAWGCEVTAFTSSARKQTEVLELGAHHILDSTNPEAIASAEGKFDYIISTVNLKLDWNLYISTLAPQGHFHFVGVVLEPLDLNLFPLLMGQRSVSASPVGSPATIATMLDFAVRHDIKPVVEQFSFDQINEAIAHLESGKAHYRVVLSHSKN

[0050] ADHA nucleotide sequence: SEQ ID NO.2

[0051]

[0052] Alcohol dehydrogenase from Bacillus stearothermophilus (ADH-hT, NCBI accession number: P42328.1, the amino acid sequence is shown in SEQ ID NO.3, and the nucleotide sequence is shown in SEQ ID NO.4).

[0053] ADH-hT amino acid sequence: SEQ ID NO.3

[0054] MKAAVVEQFKEPLKIKEVEKPTISYGEVLVRIKACGVCHTDLHAAHGDWPVKPKLPLIPGHEGVGIVEEVGPGVTHLKVGDRVGIPWLYSACGHCDYCLSGQETLCEHQKNAGYSVDGGYAEYCRAAAADYVVKIPDNLSFEEAAPIFCAGVTTYKALKVTGAKPGEWVA IYGIGGLGHVAVQYAKAMGLNVVAVDIGDEKLELAKELGADLVVNPLKEDAAKFMKEKVGGVHAAVVTAVSKPAFQSAYNSIRRGGACVLVGLPPEEMPIPIFDTVLNGIKIIGSIVGTRKDLQEALQFAAEGKVKTIIEVQPLEKINEVFDRMLKGQINGRVVLTLEDK

[0055] ADH-hT nucleotide sequence: SEQ ID NO.4

[0056]

[0057] Alcohol dehydrogenase from Pseudomonas putida KT2440 (PpADH, NCBI accession number: WP_010954666.1, the amino acid sequence is shown in SEQ ID NO.5, and the nucleotide sequence is shown in SEQ ID NO.6).

[0058] PpADH amino acid sequence: SEQ ID NO.5

[0059] MKAAVVAPGRRVDVIEKSLRPLEHGEALLKMQCCGVCHTDLHVKNGDFGDKTGVVLGHEGIGVVQEVGPGVTSLKPGDRASVAWFYQGCGHCEYCNSGNETLCRDVKNSGYTVDGGMAEACIVKADYSVKVPDGLDSAAASSITCAGVTTYKAVKISNVRPGQWIAIY GLGGLGNLALQYAKNVFNAKVIAIDVNEEQLRFASEMGADLVVNPLNEDAAKVIQAKTGGAHAAVVTAVAKGAFNSAVDALRAGGRLVAVGLPSESMDLNIPRLVLDGIEVVGSLVGTRQDLQEAFQFAAEGKVVPKVTLRPIEDINQIFDEMLEGKIKGRMVIQFEG

[0060] PpADH nucleotide sequence: SEQ ID NO.6

[0061]

[0062] Alcohol dehydrogenase from Pseudomonas entomophila strain L48 (PeADH, NCBI accession number: WP_011533867.1, the amino acid sequence is shown in SEQ ID NO.7, and the nucleotide sequence is shown in SEQ ID NO.8).

[0063] PeADH amino acid sequence: SEQ ID NO.7

[0064] MSNPTFTGWAATAPGAPLQPYRYDPGPLPDDEVEIAVEYCGVCHSDQSMIDNEWGLSRYPFIPGHEVVGRIVRTGAQVSGLDAGQRVGVGWYKGSCMHCASCMAGSHNLCGSVRPTIIGANGGFADHIRAHWAWAVPLPDTLDPALAGPLFCAGSTVFNPILAYDVKPI HRVGVVGIGGGLGHLAVRLLNAWGCEVTAFTSSLAKQAEAQALGAHKVVASTDSAALEAIAGTLDFLLVTANANLDWTAMIGTLGARGRVNFVGVVPSAIPVHVFNLMPQQKSLSASPVGSPANMATLLAFCARHQVLPQVEQFPMSQVNQAIDHLRSGKARYRIVLDASR

[0065] PeADH nucleotide sequence: SEQ ID NO.8

[0066]

[0067] A choline oxidase mutant derived from Arthrobacter cholorphenolicus (AcCO6, NCBI accession number: SDQ60757.1, the amino acid sequence is shown in SEQ ID NO.9, and the nucleotide sequence is shown in SEQ ID NO.10).

[0068] AcCO6 amino acid sequence: SEQ ID NO.9

[0069] MHIDNIENLSDRGFDYVVIGGGSAGAAVAARLSEDPDVSVALVEAGPDDRNIPEILQLDRWMELLESGYDWDYPIEPQENGNSFMRHARAKVMGGCSSHNACIAFWAPREDLDEWESKYGATGWNAANAWPLYKRL ETNQDAGPDAPHHGDSGPVHLMNVPPADPSGVALLDACEEAGIPRARFNTGTTVVNGANFFQINRRGDGTRSSSSSVSYIHPIIERDNFTLLTGLRARQLVFDADKRCTGVEVVGGARGRTHRLTARHEVILSTGAID SPKLLMLSGIGPAEHLAQHGIEVLVDSPGVGENLQDHPEGVVQFEAKQPMVQTSTQWWEIGIFTPTEDGLDRPDLMMHYGSTPRDRNTLRHGYPTTENGFSLTPNVTHARSRGTVRLRSRDFRDKPMVDPRYFTDP EGHDMRVMVAGIRKAREIAAQPAMSAWTGRELSPGVGAQTDEELQDYIRKTHNTVYHPVGTVRMGADDDGMSPLDARLRVKGVTGLRVADASVMPEHVTVNPNITVMMIGERCADLIKADYAGADALEEKELTTSFA

[0070] AcCO6 nucleotide sequence: SEQ ID NO.10

[0071]

[0072] A galactose oxidase mutant from Fusarium graminearum 2903 (GOase M 3-5 , NCBI accession number: 2WQ8_A, the amino acid sequence is shown in SEQ ID NO.11, and the nucleotide sequence is shown in SEQ ID NO.12).

[0073] GOase M 3-5 Amino acid sequence: SEQ ID NO.11

[0074] MASAPIGSAIPRNNWAVTCDSAQSGNECNKAIDGNKDTFWHTFYGANGDPKPPHTYTIDMKTTQNVNGLSVLPRQDGNQNGWIGRHEVYLSSDGTNWGSPVASGSWFADSTTKYSNFETRPARYVRLVAITEANGQPWTSIAEINVFQASSYTAPQPGLG RWGPTIDLPIVPAAAAIEPTSGRVLMWSSYRNDAFEGSPGGITLTSSWDPSTGIVSDRTVTVTKHDMFCPGISMDGNGQIVVTGGNDAKKTSLYDSSSDSWIPGPDMQVARGYQSSATMSDGRVFTIGGSFSGGVFEKNGEVYSPSSKTWTSLPNAKVNP MLTADKQGLYMSDNHAWLFGWKKGSVFQAGPSTAMNWYYTSGSGDVKSAGKRQSNRGVAPDAMCGNAVMYDAVKGKILTFGGSPDYTDSDATTNAHIITLGEPGTSPNTVFASNGLYFARTFHTSVVLPDGSFITGGQRRGIPFEDSTPVFTPEIYVPE QDTFYKQNPNSIVRAYHSISLLLPDGRVFNGGGGLCGDCTTNHFDAQIFTPNYLYDSNGNLATRPKITRTSTQSVKVGGRITISTDSSISKASLIRYGTATHTVNTDQRRIPLTLTNNGGNSYSFQVPSDSGVALPGYWMLFVMNSAGVPSVASTIRVTQ

[0075] GOase M 3-5 Nucleotide sequence: SEQ ID NO.12

[0076]

[0077] Monoamine oxidase from Pseudomonas putida KT2440 (PpMAO, NCBI accession number: WP_010953650.1, the amino acid sequence is shown in SEQ ID NO.13, and the nucleotide sequence is shown in SEQ ID NO.14).

[0078] PpMAO amino acid sequence: SEQ ID NO.13

[0079] MRIAIIGSGIAGLTCAHLLSRKHEVTVFEAEQWVGGHTHTLDVVWKGQRHAIDTGFIVFNDWTYPNFIRLLDQLQVPSQPTEMSFSVHDPIAGLEYNGHDLNTLFAQRSNLLSPGFWGMIRDILRFNRQALADLDNQRIDASTTLGDYLQANRYGQRFIDHYIVPMGSAIWSMSRADMLHFPLEFFVRFCRNHGLLSVNQRPQWRVI KGGSRSYVAPLCRPFAERIRLNCKVYRVSRDEGGVTLVSAAGTERFDNVVFACHSDQALALLENPSNQERAVLSAIDYASNDVVLHTDTRLLPRRQLAWASWNY RLGGPERAPAALTYNMNILQGIQAPTTFCVSLNQTALIDPAQVIARFQYAHPQYSVAASAAQACQEQLQGQQHSYFCGAYWGNGFHEDGVVSALKVAAHFGEQL

[0080] PpMAO nucleotide sequence: SEQ ID NO.14

[0081]

[0082] Insert alcohol dehydrogenase ADHA and monoamine oxidase PpMAO gene fusion expression plasmid pRSFDuet-(ADHA+PpMAO) nucleotide sequence: SEQ ID NO.15

[0083]

[0084] The second aspect of the present application protects the construction method of the genetically engineered bacteria as described above, including the following:

[0085] The nucleic acid molecule encoding the monoamine oxidase and the nucleic acid molecule encoding the enzyme capable of catalyzing alcohol oxidation are introduced into the host to construct and obtain the genetically engineered bacteria.

[0086] 1) Using pET-28a(+) plasmid as a template, constructing a nucleic acid molecule encoding the enzyme capable of catalyzing alcohol oxidation; using pRSFDuet-1 plasmid as a template, constructing a nucleic acid molecule encoding the monoamine oxidase; and transfecting host cells.

[0087] Preferably, the method further comprises transfecting a molecular chaperone plasmid.

[0088] Preferably, the host cell is selected from Escherichia coli BL21 (DE3).

[0089] The third aspect of the present application protects a whole-cell catalyst, comprising the genetically engineered bacteria as described above.

[0090] Preferably, the whole-cell catalyst is the crude enzyme solution of the engineered bacteria described above, or the resting cells of the engineered bacteria, or the pure enzyme expressed by the engineered bacteria, or the immobilized enzyme expressed by the engineered bacteria.

[0091] As a more preferred method, the preparation method of the crude enzyme solution of the engineering bacteria is:

[0092] 1) cultivating the genetically engineered bacteria;

[0093] II) inducing protein expression of the cultured genetically engineered bacteria with IPTG;

[0094] III) The bacterial liquid after induced expression is centrifuged to collect the bacterial cells, the bacterial cells are washed with phosphate buffer, and then the bacterial cells are resuspended with phosphate buffer to obtain the whole-cell catalyst.

[0095] Further preferably, in I), the engineered bacteria are inoculated in a liquid LB medium containing 50 μg / mL kanamycin and 20 μg / mL chloramphenicol for culture; and the inoculation amount is 1% (v / v) and inoculated in a liquid LB medium containing 50 μg / mL kanamycin, 20 μg / mL chloramphenicol and 0.5 mg / mL L-arabinose for further culture. The culture temperature is 37°C, the culture time is 8 hours, and the culture is shaken at 200 rpm.

[0096] Further preferably, in II), when cultured to OD 600When the pH reaches 0.6-0.8, IPTG is added for induction. The final concentration of IPTG is 0.01 mM, the induction temperature is 18°C, and the induction time is 16 h.

[0097] Further preferably, in III), the centrifugal speed is 4000 rpm and the centrifugal time is 10 min.

[0098] The fourth aspect of the present application protects the use of the genetically engineered bacteria as described above or the whole-cell catalyst as described above in the preparation of quinoline compounds.

[0099] The fifth aspect of the present application protects a method for preparing a quinoline compound, comprising the following steps:

[0100] The amino alcohol is used as a substrate and the genetically engineered bacteria or the whole cell catalyst as described above are used to react to obtain the quinoline compound.

[0101] The present invention uses amino alcohol substrates to synthesize quinoline, which can avoid the problem of two substrates being required for condensation reaction in chemical methods, thereby causing a waste of raw materials. At the same time, under the mediation of the genetically engineered bacteria as a biocatalyst, the biocatalytic method can be carried out under mild conditions and has the characteristics of being simple and efficient. Compared with the oxidative dehydrogenation process of 1,2,3,4-tetrahydroquinoline, this method has the advantage of relatively cheap and readily available raw materials, and has application prospects.

[0102] The reaction process is shown below:

[0103]

[0104] Preferably, the amino alcohol is selected from 3-(2-aminophenyl)-1-propanol.

[0105] The specific principle is: using 3-(2-aminophenyl)-1-propanol as a substrate, alcohol dehydrogenase or alcohol oxidase is used to catalyze the oxidative dehydrogenation of the substrate to generate 2-aminophenylpropanal, and then the compound undergoes an intramolecular ammonia aldehyde condensation reaction and dehydrates to form an imine intermediate. After the imine intermediate undergoes tautomerism, an oxidative dehydrogenation reaction occurs under the catalysis of air or monoamine oxidase to achieve aromatization.

[0106] Preferably, the reaction temperature is 20-50° C. More preferably, the temperature may be 20-32° C., 28-43° C., 35-50° C., or 27° C., 30° C., 45° C., or 50° C.

[0107] Preferably, the reaction time is 24 to 48 hours. More preferably, the temperature can be 24 to 32 hours, 28 to 36 hours, 35 to 48 hours, or 24 hours.

[0108] Preferably, based on the total volume of the reaction system, the concentration of the amino alcohol is 1-5 mM.

[0109] Preferably, the reaction further comprises adding a coenzyme, wherein the coenzyme is selected from NAD+ and / or NADH.

[0110] More preferably, based on the total volume of the reaction system, the concentration of the coenzyme is 1-5 mM.

[0111] Preferably, based on the total volume of the reaction system, the amount of the catalyst added is calculated as the wet weight of the cells after centrifugation at 4000 rpm for 10 minutes, and the amount of the genetically engineered bacteria added is 4.25-17.00 mg / mL.

[0112] Preferably, the pH value of the reaction is 6 to 9. More preferably, it can be 6 to 7.2, 6.9 to 8.3, or 8.1 to 9. The pH value of the reaction is controlled to be 7 to 8 using a sodium phosphate buffer solution.

[0113] More specifically, the reaction temperature is 30° C., the reaction time is 24 h, and the reaction pH is 8.

[0114] Preferably, the method further comprises separation and purification. The separation and purification comprises adding ethyl acetate for extraction after the reaction is completed, drying the organic layer, filtering, concentrating the filtrate, eluting with n-hexane and ethyl acetate as mobile phases, and concentrating by rotary evaporation to obtain the quinoline compound.

[0115] The invention screens enzymes from different sources that can catalyze alcohol oxidation. When the enzymes are used to catalyze amino alcohol substrates, the yield of quinoline compounds is 1-19%, among which ADHA from Cyanobacterium Synechocystis PCC 6803 has the highest yield when catalyzed. On this basis, a strain of fusion expression of ADHA from Cyanobacterium Synechocystis and monoamine oxidase PpMAO is constructed. When the strain catalyzes amino alcohol substrates, the yield of quinoline compounds is increased by 3.3 times compared with ADHA. Furthermore, molecular chaperone plasmids pKJE7 or pGro7 are simultaneously expressed, and it is found that the yields are increased by 6.1% and 9.8% compared with those not simultaneously expressed.

[0116] In order to make those skilled in the art better understand the scheme of the present invention, the technical scheme of the present invention is clearly and completely described below in conjunction with specific embodiments. It should be noted that the following detailed descriptions are all exemplary and are only embodiments of a part of the present invention, rather than all embodiments.

[0117] Based on the embodiments of the present invention, all other embodiments obtained by ordinary technicians in this field without making any creative work should fall within the scope of protection of the present invention.

[0118] Unless otherwise specified, all technical and scientific terms used herein have the same meanings as those commonly understood by those of ordinary skill in the art to which this application belongs. The experimental materials used in the examples of the present invention are all conventional experimental materials in the art and can be purchased through commercial channels. Experimental methods without specifying detailed conditions were performed according to conventional experimental methods or according to the operating instructions recommended by the supplier.

[0119] The experimental methods in the examples of this application are all conventional methods unless otherwise specified.

[0120] The genes used in the examples of this application were synthesized by Universal Biosystems (Anhui) Co., Ltd. E. coli BL21 (DE3) strains were purchased from Novagen; DNA marker, PrimeStar DNA polymerase, and other molecular biology experimental reagents were purchased from TaKaRa. For specific operations of gene cloning and expression, please refer to "Molecular Cloning Experiment Guide" edited by J. Sambrook et al.

[0121] This application uses ultra-high performance liquid chromatography-triple quadrupole-time of flight mass spectrometry (UPLC-Triple-TOF-MS, LC-MS) for LC-MS analysis, and uses Agilent xdb-C18 (5μm, 4.6×250mm) chromatographic column for analysis. Mobile phase A is acetonitrile and mobile phase B is water. The gradient elution program is used for analysis: 0min 50% A, 15min 50% A, 21min 95% A. The flow rate is 1mL / min, the UV detection wavelength is 313nm, and the column temperature is 30°C. For specific peak conditions of each related substance, please see the attached Figure 1-3 .

[0122] Example 1 Construction of genetically engineered bacteria

[0123] In this Example 1, enzymes capable of catalyzing alcohol oxidation from different sources were screened, and genetically engineered bacteria expressing different enzymes were constructed.

[0124] 1.1. Screening of alcohol dehydrogenase

[0125] According to literature reports, alcohol dehydrogenases from four sources were screened, specifically medium-chain alcohol dehydrogenase (ADHA) from Cyanobacterium synechocystis PCC 6803, alcohol dehydrogenase (ADH-hT) from Bacillus stearothermophilus, alcohol dehydrogenase (PpADH) from Pseudomonas putida KT2440, and alcohol dehydrogenase (PeADH) from Pseudomonas entomophilastrain L48, numbered E1, E2, E3, and E4, respectively, and then connected to the pET-28a (+) vector and transformed into Escherichia coli competent cells. The specific operation is as follows:

[0126] Alcohol dehydrogenase (ADH-hT) from Bacillus stearothermophilus has been successfully used in the oxidation process of long-chain fatty primary alcohols. Its amino acid sequence was used as a template for BLASTp analysis in the National Center for Biotechnology Information (NCBI) database (https: / / www.ncbi.nlm.nih.gov / ), and PpADH from Pseudomonas putida KT2440 and PeADH from Pseudomonas entomophila strain L48 were selected as candidate enzymes of alcohol dehydrogenase.

[0127] It has also been reported that the medium-chain alcohol dehydrogenase ADHA from Cyanobacterium synechocystis PCC 6803 has a relatively broad substrate spectrum and can catalyze the oxidation of many long-chain aliphatic or aromatic primary alcohols, especially has a good catalytic efficiency for the substrate cinnamyl alcohol, so it is also regarded as a candidate alcohol dehydrogenase.

[0128] 1.2. Screening of alcohol oxidase

[0129] In addition to alcohol dehydrogenase, alcohol oxidase can also catalyze alcohol oxidation reactions. According to literature reports, two sources of alcohol oxidase were screened, specifically the choline oxidase mutant AcCO6 from Arthrobacter cholorphenolicus and the galactose oxidase mutant GOaseM from Fusarium graminearum. 3-5 , numbered E5 and E6 respectively.

[0130] The choline oxidase mutant AcCO6 from Arthrobacter cholorphenolicus has also been reported to have good catalytic activity towards cinnamyl alcohol.

[0131] In addition, the galactose oxidase mutant GOase M from Fusarium graminearum 3-5 It can also catalyze the oxidation reaction of amino alcohol compounds and is used to synthesize indole structures.

[0132] In summary, six candidate enzymes were selected for research. The details of the six candidate enzymes are shown in Table 1.

[0133] Table 1

[0134]

[0135]

[0136] The gene sequences of alcohol oxidase / alcohol dehydrogenase in Table 1 were codon optimized and sent to General Biosystems (Anhui) Co., Ltd. for full gene synthesis and cloned into the recombinant expression plasmid pET-28a(+) to form 6 recombinant expression vectors. The steps for constructing the recombinant expression vectors are as follows:

[0137] (1) Primer design:

[0138] Table 2

[0139] Primer name Sequence (5'-3') Sequence number F-ADHA AAATTAACTCGAGCACCACCACCACCA SEQ ID NO.16 R-ADHA ATAGGCCTTGATCATATGGCTGCCGC SEQ ID NO.17 F-ADH-hT GGAAGATAAACTCGAGCACCACCACCACCA SEQ ID NO.18 R-ADH-hT GCGGCCTTCATATGGCTGCCGCGC SEQ ID NO.19 F-PpADH CGAAGGCTAACTCGAGCACCACCACC SEQ ID NO.20 R-PpADH GCAGCTTTCATATGGCTGCCGCGCG SEQ ID NO.21 F-PeADH GCCAGCCGCTAACTCGAGCACCACC SEQ ID NO.22 R-PeADH CGTGGGATTGCTCATATGGCTGCCG SEQ ID NO.23 F-AcCO6 AGCTTTGCCCTCGAGCACCACCACC SEQ ID NO.24 R-AcCO6 ATCGATATGCATATGGCTGCCGCGC SEQ ID NO.25 <![CDATA[F-GOase M 3-5 ]]> CGTTACTCAGTGACTCGAGCACCACCAC SEQ ID NO.26 <![CDATA[F-GOase M 3-5 ]]> GGAGGCCATATGGCTGCCGCGC SEQ ID NO.27

[0140] (2) Construction of plasmid vector skeleton:

[0141] Using pET-28a(+) plasmid as a template, PCR was performed using the primers in Table 2 above:

[0142] PCR amplification system:

[0143] PCR amplification conditions:

[0144] 1) Pre-denaturation: 95℃ for 5min;

[0145] 2) Denaturation: 98°C for 10 s; annealing: 58°C for 15 s; extension: 72°C for 60 s; 30 cycles in total;

[0146] 3) Post-extension: 72°C for 10 min;

[0147] 4) Store at 4℃.

[0148] Each PCR amplification product was subjected to agarose gel electrophoresis, and the template was digested with Dpn Ι enzyme after recovery to obtain the purified and recovered enzyme gene fragment. The specific digestion system is: Dpn Ι enzyme 1 μL, PCR product 17 μL, Buffer 2 μL. The template digestion can be completed at 37 ° C for 2 hours to obtain the enzyme gene fragment.

[0149] The obtained enzyme gene fragment and backbone vector pET-28a(+) were homologously recombined to obtain a recombinant expression vector. Gene recombination was performed according to the ClonExpress IIOne Step Cloning Kit provided by Nanjing Novogene Biotechnology Co., Ltd. The recombination system (10 μL) was as follows: 1 μL recombinase (ExnaseⅡ), 5 μL CEⅡBuffer, 1 μL enzyme gene fragment, 7 μL backbone vector corresponding to the enzyme gene, mixed evenly and placed at 37°C for 1h to complete the construction of the recombinant expression vector, and 6 recombinant expression vectors were obtained.

[0150] The six recombinant expression vectors were respectively transferred into the expression host E. coli BL21 (DE3). The genetically engineered bacteria verified by sequencing were strains expressing alcohol oxidase or alcohol dehydrogenase. Then, glycerol with a final concentration of 25% was added and stored at -80°C for later use.

[0151] Example 2 Catalytic Preparation of Quinoline Compounds from Amino Alcohol Substrates

[0152] In this Example 2, the six engineered bacteria obtained in Example 1 catalyze 3-(2-aminophenyl)-1-propanol to prepare quinoline compounds. Specifically, the following are included:

[0153] 2.1. Cultivation of microorganisms

[0154] Liquid LB medium composition: peptone 10g / L, yeast powder 5g / L, NaCl 10g / L, dissolved in deionized water and fixed to volume, sterilized at 121℃ for 20min, and set aside. If it is solid LB medium, add 15g / L agar.

[0155] 1) The engineered bacteria containing alcohol oxidase gene or alcohol dehydrogenase gene obtained in Example 1 were inoculated into 5 mL of liquid LB medium (containing 50 μg / mL kanamycin) and cultured at 37° C. and 200 rpm for about 8 h.

[0156] 2) Inoculate 50 mL of liquid LB medium (containing 50 μg / mL kanamycin) at a 1% (v / v) inoculum and culture. 600 After reaching 0.6-0.8, the inducer IPTG (final concentration 0.01 mM) was added and induced at 18°C ​​for 16 h.

[0157] 3) After the culture is completed, the culture solution is poured into a 100 mL centrifuge tube and centrifuged at 4000 rpm for 10 min. The supernatant is discarded, the bacterial cells are collected, and the cells are washed twice with 50 mM phosphate buffer (pH 8.0). Thereafter, the cells are stored in a -80°C ultra-low temperature refrigerator for later use.

[0158] 2.2 Preparation of crude enzyme solution

[0159] The bacterial cells stored at -80°C obtained in step 2.1 were resuspended in 12.5 mL of 50 mM phosphate buffer (pH 8.0), and the bacterial cell suspension was disrupted by ultrasonication. The supernatant obtained after centrifugation was the target crude enzyme solution.

[0160] 2.3. Catalytic Preparation of Quinoline Compounds from 3-(2-aminophenyl)-1-propanol

[0161] Reaction system (1 mL): Take 0.9 mL of the crude enzyme solution obtained in step 2.2, add 5 mM 3-(2-aminophenyl)-1-propanol substrate (prepared with DMSO, DMSO concentration controlled to 5%, v / v) and 5 mM NAD + The prepared reaction system was placed in a shaker at 30°C and shaken at 220 rpm for 24 h.

[0162] At the same time, phosphate buffer (pH 8.0) was used instead of crude enzyme solution as a control.

[0163] Each group of samples was diluted 10 times with acetonitrile and then qualitatively analyzed by LC-MS. The content of quinoline compounds in the samples was detected by LC-MS, and the concentration (g / L) of the product quinoline compounds in the reaction solution was calculated based on the substrate standard curve.

[0164] Reaction conversion rate = [(initial substrate concentration - substrate concentration after reaction) / initial substrate concentration] × 100%

[0165] Reaction yield = actual product concentration (g / L) / theoretical product concentration (g / L) × 100%

[0166] Results Figure 1 , Figure 2 and Table 3.

[0167] Table 3

[0168] serial number Protein name Quinoline yield (%) Conversion rate (%) E0 Control 2 2 <![CDATA[E1]]> ADHA 19 93 <![CDATA[E2]]> ADH-hT 7 10 <![CDATA[E3]]> PpADH 1 1 <![CDATA[E4]]> PeADH 15 53 <![CDATA[E5]]> AcCO6 5 7 <![CDATA[E6]]> <![CDATA[GOase M 3-5 ]]> 2 12

[0169] Figure 1 The UV absorption spectrum of the substrate 3-(2-aminophenyl)-1-propanol detected by LC-MS; Figure 2 The figure is the UV absorption spectrum of the product quinoline detected by LC-MS.

[0170] As can be seen from Table 3, compared with the control, E1, E2, E3, E4, E5 and E6 can all catalyze the reaction of 3-(2-aminophenyl)-1-propanol to produce quinoline compounds, among which the yield of quinoline compounds catalyzed by E1 can reach 19%, which is the highest value.

[0171] Example 3 Construction, cultivation and screening of strains co-expressing ADHA and PpMAO

[0172] 3.1. Construction of a strain co-expressing alcohol dehydrogenase ADHA and monoamine oxidase PpMAO

[0173] According to literature reports, monoamine oxidase PpMAO can catalyze the oxidative dehydrogenation aromatization of 1,2,3,4-tetrahydroquinoline. In this study, the aromatization process of the imine intermediate is also involved. Therefore, coupling PpMAO may promote the aromatization process and thus facilitate the synthesis of the target product quinoline. Therefore, based on the optimal alcohol dehydrogenase ADHA screened in Example 2, ADHA and PpMAO were fused and expressed.

[0174] The two enzyme genes were cloned into the plasmid pRSFDuet-1 at the same time to obtain the fusion plasmid pRSFDuet-(ADHA+PpMAO);

[0175] The steps for constructing the fusion plasmid are as follows:

[0176] 1) Primer design

[0177] Table 4

[0178]

[0179] 2) Construction of fusion plasmid backbone

[0180] The plasmid backbone construction is carried out in the order of inserting the ADHA gene first and then the PpMAO gene, that is, the plasmid backbone for inserting the ADHA gene is first constructed, and on this basis, the plasmid backbone for inserting the PpMAO gene is further constructed.

[0181] Using the pRSFDuet-1 plasmid as a template, PCR was performed using the primers listed in Table 4 above.

[0182] The PCR amplification system is shown in Table 5.

[0183] Table 5

[0184]

[0185]

[0186] PCR amplification conditions:

[0187] 1) Pre-denaturation: 95℃ for 5min;

[0188] 2) Denaturation: 98°C for 10 s; annealing: 58°C for 15 s; extension: 72°C for 60 s; 30 cycles in total;

[0189] 3) Post-extension: 72°C for 10 min;

[0190] 4) Store at 4℃.

[0191] The PCR product was subjected to agarose gel electrophoresis, and the plasmid template was digested with Dpn Ι enzyme after recovery to obtain the purified and recovered vector backbone gene fragment. The specific digestion system was: Dpn Ι enzyme 1 μL, PCR product 17 μL, Buffer 2 μL. The template digestion can be completed at 37 ° C for 2 hours.

[0192] The obtained ADHA enzyme gene fragment and the backbone vector pRSFDuet-1 were homologously recombined to obtain a recombinant expression vector. Gene recombination was performed according to the ClonExpress IIOne Step Cloning Kit provided by Nanjing Novozyme Biotechnology Co., Ltd. The recombination system (10 μL) was as follows: 1 μL recombinase (ExnaseⅡ), 5 μL CEⅡBuffer, 1 μL alcohol dehydrogenase ADHA gene, 7 μL backbone vector corresponding to the enzyme gene, mixed evenly and placed at 37°C for 1h to complete the construction of the ADHA recombinant plasmid.

[0193] The above-mentioned recombinant plasmid with the ADHA gene inserted was used as a plasmid template to perform PCR amplification for inserting the backbone of PpMAO. The PCR amplification conditions were the same as those for inserting ADHA into the backbone vector pRSFDuet-1, and the primers used were the primers for inserting the PpMAO gene (see Table 4 for details). The subsequent template digestion and recombination steps were the same as above (the gene inserted during recombination was PpMAO, and the backbone was the newly constructed backbone vector). At this point, the construction of the fusion plasmid pRSFDuet-(ADHA+PpMAO) was completed. Further, the transformation was transferred into the expression host E.coli BL21 (DE3) to obtain the engineered bacteria Duet-(ADHA+PpMAO) that simultaneously expresses ADHA and PpMAO.

[0194] In addition, to optimize the expression of the enzyme, the molecular chaperone plasmid pGro7 or pKJE7 can be further added. Specifically, the fusion plasmid pRSFDuet-(ADHA+PpMAO) and the molecular chaperone plasmid were simultaneously transferred into the expression host E. coli BL21 (DE3) to obtain Duet-(ADHA+PpMAO)+pKJE7 and Duet-(ADHA+PpMAO)+pGro7, respectively, as shown in Table 6.

[0195] After sequencing verification, glycerol with a final concentration of 25% was added to the bacterial solution of the obtained engineered bacteria and stored at -80°C for later use.

[0196] Table 6

[0197]

[0198]

[0199] 3.2. Cultivation of co-expression strains

[0200] Liquid LB medium composition: peptone 10g / L, yeast powder 5g / L, NaCl 10g / L, dissolved in deionized water and fixed to volume, sterilized at 121℃ for 20min, and set aside. If it is solid LB medium, add 15g / L agar.

[0201] 1) The three co-expression engineered bacteria constructed in step 3.1 were inoculated into 5 mL of liquid LB medium (containing 50 μg / mL kanamycin and 20 μg / mL chloramphenicol) and cultured at 37°C and 200 rpm for about 8 h.

[0202] 2) Inoculate 50 mL of liquid LB medium (containing 50 μg / mL kanamycin, 20 μg / mL chloramphenicol and 0.5 mg / mL L-arabinose) at a 1% (v / v) inoculum and culture. 600 After reaching 0.6-0.8, the inducer IPTG (final concentration 0.01 mM) was added and induced at 18°C ​​for 16 h.

[0203] 3) After the culture is completed, the culture solution is poured into a 100 mL centrifuge tube and centrifuged at 4000 rpm for 10 min. The supernatant is discarded, the bacterial cells are collected, and the cells are washed twice with 50 mM phosphate buffer (pH 8.0). Then, the crude enzyme solution is obtained and stored in a -80°C ultra-low temperature refrigerator for later use.

[0204] 3.3. Screening of strains co-expressing alcohol dehydrogenase ADHA and monoamine oxidase PpMAO

[0205] Reaction system (3 mL): Take 2.85 mL of crude enzyme solution, add 5 mM 3-(2-aminophenyl)-1-propanol substrate (prepared with DMSO, DMSO concentration controlled to 5%, v / v) and 5 mM NAD + , place the prepared reaction system in a constant temperature water bath at 30°C, do not seal the reaction tube, stir magnetically, and react for 24 hours.

[0206] After the reaction was completed, 100 μL of each was taken out and added to 900 μL of acetonitrile as a sample and subjected to LC-MS analysis to detect the content of quinoline in each reaction system. The results are shown in Table 7.

[0207] Table 7

[0208] serial number Engineering bacteria Conversion rate (%) Quinoline yield (%) <![CDATA[E7]]> Duet-(ADHA+PpMAO) 88 82 <![CDATA[E8]]> Duet-(ADHA+PpMAO)+pKJE7 100 87 <![CDATA[E9]]> Duet-(ADHA+PpMAO)+pGro7 100 90

[0209] As can be seen from Table 7, the conversion rates of the substrate 3-(2-aminophenyl)-1-propanol catalyzed by E7, E8 and E9 were 88%, 100% and 100%, respectively. The production of quinoline compounds can be detected in the reaction systems catalyzed by the three co-expression engineered strains, among which the yield catalyzed by E9 can reach 90%, which is the highest value.

[0210] Example 4 Catalytic Preparation of Quinoline Compounds by 3-(2-Aminophenyl)-1-propanol

[0211] In this embodiment 4, an amplification experiment is performed on the basis of embodiment 3. The details are as follows:

[0212] Reaction system (30 mL): Add a magnetic stirrer to a 50 mL three-necked flask, followed by 22.7 mg 3-(2-aminophenyl)-1-propanol (final concentration 5 mM), 1.5 mL DMSO, and 28.5 mL Duet-(ADHA-PpMAO) + pGro7 crude enzyme solution. Use 50 mM pH 8.0 sodium phosphate (NaPi) buffer to make up the reaction volume to 30 mL. Stir magnetically in a constant temperature water bath at 30 °C for 24 h.

[0213] After the reaction is completed, 3 volumes (90 mL) of ethyl acetate are added for extraction, and the organic layer is subsequently taken out and dried using MgSO4, filtered, and concentrated in vacuo. Then normal hexane and ethyl acetate are used as mobile phases to carry out gradient elution through a silica gel column. The target product is collected, and then concentrated by rotary evaporation to obtain the target quinoline product after crystallization. The target product content is analyzed by LC-MS to detect the quinoline content after purification.

[0214] Test results such as Figure 3 As shown, the ADHA and PpMAO co-expression strain carrying the molecular chaperone pGro7 has a good catalytic effect on 3-(2-aminophenyl)-1-propanol, with a conversion rate of up to 100% and a quinoline yield of 96%.

Claims

1. A genetically engineered bacterium that catalyzes the production of quinoline compounds, characterized in that: Monoamine oxidase and an enzyme capable of catalyzing alcohol oxidation, the enzyme capable of catalyzing alcohol oxidation being selected from alcohol oxidase or alcohol dehydrogenase, are expressed.

2. The genetically engineered bacterium according to claim 1, characterized in that The monoamine oxidase is derived from Pseudomonas putida KT2440; And / or, the alcohol dehydrogenase is selected from one or more of Bacillus stearothermophilus, Pseudomonas putida KT2440, Pseudomonas sentomophila strain L48 and Cyanobacterium synechocystis PCC6803; And / or, the alcohol oxidase is selected from one or both of a choline oxidase mutant and a galactose oxidase mutant.

3. The genetically engineered bacterium according to claim 2, characterized in that: The nucleotide sequence of the monoamine oxidase comprises the sequence shown in SEQ ID NO.14; And / or, the nucleotide sequence of the alcohol dehydrogenase comprises one or more of the sequences shown in SEQ ID NO.2, SEQ ID NO.4, SEQ ID NO.6 and SEQ ID NO.8; And / or, the choline oxidase mutant is derived from Arthrobacter cholorphenolicus; and / or, the galactose oxidase mutant is derived from Fusarium graminearum 2903.

4. The genetically engineered bacterium according to claim 3, characterized in that The nucleotide sequence of the choline oxidase mutant comprises the sequence shown in SEQ ID NO.10; And / or, the nucleotide sequence of the galactose oxidase mutant comprises the sequence shown in SEQ ID NO.

12.

5. The genetically engineered bacterium according to claim 1, characterized in that A molecular chaperone plasmid is also expressed, and the molecular chaperone plasmid is selected from one or both of pGro7 and pKJE7; And / or, the engineered bacteria is selected from Escherichia coli.

6. The method for constructing a genetically engineered bacterium according to any one of claims 1 to 5, characterized in that: The method comprises the following steps: introducing a nucleic acid molecule encoding the monoamine oxidase and a nucleic acid molecule encoding the enzyme capable of catalyzing alcohol oxidation into a host, and constructing and obtaining the genetically engineered bacteria.

7. A whole cell catalyst, characterized in that Comprising the genetically engineered bacteria according to any one of claims 1 to 5.

8. Use of the genetically engineered bacteria according to any one of claims 1 to 5 or the whole-cell catalyst according to claim 7 in the preparation of quinoline compounds.

9. A method for preparing a quinoline compound, characterized in that: The steps include: The quinoline compound is obtained by using amino alcohol as a substrate and using the genetically engineered bacteria as described in any one of claims 1 to 5 or the whole-cell catalyst as described in claim 7 to carry out the reaction.

10. The preparation method according to claim 9, characterized in that: The amino alcohol is selected from 3-(2-aminophenyl)-1-propanol; And / or, the reaction temperature is 20-50°C.